PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.86%
Negative net income growth while CRWV stands at 7.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.92%
Less D&A growth vs. CRWV's 26.15%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-208.20%
Negative yoy deferred tax while CRWV stands at 3.70%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.47%
SBC growth while CRWV is negative at -21.18%. John Neff would see competitor possibly controlling share issuance more tightly.
132.15%
Slight usage while CRWV is negative at -110.52%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
115.46%
AR growth while CRWV is negative at -35.57%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-170.81%
Negative yoy inventory while CRWV is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
121.28%
A yoy AP increase while CRWV is negative at -663.96%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
142.54%
Growth well above CRWV's 112.72%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
134.20%
Well above CRWV's 23.14%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
75.32%
Some CFO growth while CRWV is negative at -510.76%. John Neff would note a short-term liquidity lead over the competitor.
8.95%
Some CapEx rise while CRWV is negative at -74.30%. John Neff would see competitor possibly building capacity while we hold back expansions.
-2102.24%
Negative yoy acquisition while CRWV stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-248.22%
Negative yoy purchasing while CRWV stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
118.36%
We have some liquidation growth while CRWV is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-1226.97%
We reduce yoy other investing while CRWV is 202.79%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1292.85%
Both yoy lines negative, with CRWV at -70.42%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
63.92%
Stock issuance far above CRWV's 4.88%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-18.69%
We cut yoy buybacks while CRWV is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.